Back to Results
First PageMeta Content
Bristol-Myers Squibb / Organofluorides / Medicine / Purines / Non-nucleoside reverse transcriptase inhibitors / Lamivudine / Cipla / Abacavir / Nevirapine / Chemistry / Organic chemistry / Cyclopropanes


APPENDIX I THE PRESIDENT’S EMERGENCY PLAN FOR AIDS RELIEF SOURCES OF FUNDING (Dollars in Millions)
Add to Reading List

Document Date: 2014-09-01 00:42:39

Open Document

File Size: 100,46 KB

Share Result on Facebook

Company

Strides Arcolabs Cipla Limited / Cipla Limited / USG / Zidovudine (300mg tablets) Company Barr Laboratories / Aurobindo Pharma Aurobindo Pharma Cipla Limited / Strides Arcolabs Pharmacare Limited / Aurobindo Pharma Cipla Limited / Aurobindo Pharma / /

Country

Rwanda / Kenya / Zambia / Uganda / Vietnam / Guyana / Haiti / Tanzania / Nigeria / Botswana / Ethiopia / Mozambique / South Africa / Namibia / /

Event

FDA Phase / /

Facility

Laboratory Infrastructure / /

IndustryTerm

20mg/ml oral solution / Prevention of HIV / 10mg/ml oral solution / AIDS Prevention / /

MedicalCondition

TB / Pediatric AIDS Working Group Tuberculosis / HIV / malaria / AIDS / HIV/AIDS / /

MedicalTreatment

Counseling / /

MusicGroup

Scientific / /

Organization

National Institute of Health / United States Agency for International Development / Working Group Male Circumcision Taskforce Subcommittee on HIV / FDA / Department of Defense / Global Fund / Global Trust Fund / /

Position

PRESIDENT / Global AIDS Coordinator / General / Private / /

Product

Efavirenz / Zidovudine / 600mg / Abacavir (300mg) / 150mg / Nevirapine (200mg) / Lamivudine (150mg)/Zidovudine (300mg) / Lamivudine (150mg)/Zidovudine (300mg)/Nevirapine (200mg) / Nevirapine / 40mg / Abacavir / 300mg / lamivudine / Didanosine / 200mg / Stavudine / /

URL

http /

SocialTag